Integration of local and central laboratory functions in a worldwide multicentre study: Experience from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study

被引:70
作者
Nesbitt, G. Selby
Smye, Michael
Sheridan, Brian
Lappin, Terence R. J.
Trimble, Elisabeth R. [1 ]
机构
[1] Queens Univ Belfast, Royal Victoria Hosp, Clin Biochem & Metab Med, Inst Clin Sci,Dept Clin Biochem, Belfast BT12 6BA, Antrim, North Ireland
[2] Royal Victoria Hosp, Dept Haematol, Belfast BT12 6BA, Antrim, North Ireland
[3] Queens Univ Belfast, Belfast BT9 7AB, Antrim, North Ireland
[4] Queens Univ Belfast, Clin Biochem & Metab Med, Belfast BT12 6BJ, Antrim, North Ireland
关键词
D O I
10.1177/174077450607695
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background Measurement of glucose in multiple Field Laboratories requires rigorous standardization when patients and caregivers are masked, unless predefined thresholds are met. Local misclassification of participants at the thresholds can introduce recruitment bias and adversely affect the integrity of study findings. Purpose To describe the challenges and the approach to meeting them in measuring glucose, HbA1c, and C-peptide in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. HAPO is an observational epiderniologic study of 25 000 pregnant women from 15 centres in 10 countries, designed to clarify unanswered questions on associations of maternal glycemia, less severe than overt diabetes mellitus, with risks of adverse pregnancy outcome. Methods Glucose tolerance (75g two-hour OGTT) is assessed locally at 24-32 weeks' gestation, with results masked if fasting and two-hour plasma glucose are <= 5.8 mmol/L and <= 11.1 mmol/L, respectively. For analysis of outcomes HAPO utilizes measurements of glucose, C-peptide, and HbA1c on frozen samples in a Central Laboratory; measurement of HbA1c on stored, frozen blood also creates special challenges. A common external quality assessment scheme was used to standardize glucose measurements between Field Centre and Central Laboratories before and during data collection. Results Agreement between Field Centres and the Central Laboratory in rates above the masking thresholds has been excellent (Kappa = 0.79, P < 0.001), with rates of 1.8 and 1.7% respectively. Percent technical error for Central Laboratory OGTT measurements of glucose, C-pepticle, and HbAlc, were 2.0, 4.2, and 2.0, respectively. Limitations It is not possible to assess if comparable results could have been obtained with a less rigorous approach to standardization. Conclusions HAPO has been successful in ensuring comparability of glucose measurement between its Central Laboratory and Field Centre laboratories and in measuring its key metabolites with accuracy and precision. Recruitment bias based on glucose measurement has been avoided.
引用
收藏
页码:397 / 407
页数:11
相关论文
共 14 条
[1]  
[Anonymous], 2005, DIABETES CARE, V28, P150
[2]  
[Anonymous], WHOEMC973
[3]  
Bray GA, 2000, DIABETES CARE, V23, P1619
[4]   The status of diabetes control in Asia - a cross-sectional survey of 24 317 patients with diabetes mellitus in 1998 [J].
Chuang, LM ;
Tsai, ST ;
Huang, BY ;
Tai, TY .
DIABETIC MEDICINE, 2002, 19 (12) :978-985
[5]  
Contreras M, 2002, INT J GYNECOL OBSTET, V78, P69
[6]   Estimating laboratory precision of urinary albumin excretion and other urinary measures in the international study on macronutrients and blood pressure [J].
Dyer, AR ;
Greenland, P ;
Elliott, P ;
Daviglus, ML ;
Claeys, G ;
Kesteloot, H ;
Chan, Q ;
Ueshima, H ;
Stamler, J .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 160 (03) :287-294
[7]   1ST-TRIMESTER HEMOGLOBIN-A1 AND RISK FOR MAJOR MALFORMATION AND SPONTANEOUS-ABORTION IN DIABETIC PREGNANCY [J].
GREENE, MF ;
HARE, JW ;
CLOHERTY, JP ;
BENACERRAF, BR ;
SOELDNER, JS .
TERATOLOGY, 1989, 39 (03) :225-231
[8]   Discordance rate, a new concept for combining diagnostic decisions with analytical performance characteristics. 1. Application in method or sample system comparisons and in defining decision limits [J].
Haeckel, R ;
Wosniok, W ;
Puentmann, I .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (03) :347-355
[9]   THE CENTRAL BIOCHEMISTRY LABORATORY IN THE MULTICENTER KROC STUDY - PROBLEMS AND PROPOSALS [J].
HOME, PD ;
ALBERTI, KGMM ;
RODGER, NW ;
BURRIN, JM .
DIABETES, 1985, 34 :17-21
[10]  
Meinert C. L., 1986, CLIN TRIALS DESIGN C